PubMed Health⌕ Search

PubMed · 10590660

[In Process Citation]

Abstract

INTRODUCTION AND AIMS: Transposition of the Major Arteries (TMA) is defined as atrioventricular concordance with ventriculoarterial discordance. Systemic and pulmonary circulation are in parallel and a communication between the two is essential for survival. Progress in echocardiography, cardiac catheterization, treatment with prostaglandin and cardiac surgery have reduced mortality and contributed to the adoption of Jatene's operation as the treatment of choice for TMA. Long term success depends on the continued patency of the coronary arteries and on the preservation of left ventricular function. Reports of significant silent coronary lesions and the uncertainty of long-term growth of the arterial anastomosis lead us to study coronary circulation in TMA. METHODS: Anatomic analysis of 130 heart specimens was followed by a prospective angiographic study in 50 children with TMA to select appropriate views for the diagnosis of the coronary anatomy. Troponin-T was tested as marker of myocardial ischaemia in 54 children and myocardial function was evaluated in 30 children after Jatene's operation with myocardial perfusion scintigraphy, dobutamine-induced stress echocardiography and angiocardiography. Permeability of the coronary arteries was assessed with angiocardiography. RESULTS: The morphologic study led us to conclude that the right-anterior aorta was present in 65% of hearts with TMA, followed by side-by-side great arteries; the pulmonary orifice was of the same size or larger than the aortic orifice in the majority of TMA. Major non-alignment of the aortic and pulmonary comissures was recorded in 14 to 30% of TMA specimens. The diameter of the coronary orifices was larger in TMA when compared to a normal heart. In cases with right anterior aorta, normal coronary pattern was the most frequent, followed by the pattern where the circumflex coronary artery (Cx) emerged from the right coronary (RCA). In cases with side-by-side great arteries, both patterns were equally frequent. In TMA with normal coronary pattern, the angles between the right and left coronary arteries and the aorta at the origin were equal and similar to the RCA angle with the aorta in a normal heart (about 90 degrees). The RCA in TMA was longer than in a normal heart. Although we could not find any publication reporting the angles and lengths of the coronary arteries, these measurements must be considered whenever translocation of the coronary arteries is attempted. A laid-back aortogram led us to the correct diagnosis of the coronary anatomy prior to surgery. Our study confirmed that MBCK had very low specificity for myocardial ischaemia but cTnT values correctly evaluated the extent of the myocardial lesion. Postoperative angiograms showed patent coronary arteries with no stenosis in all cases and myocardial perfusion was well preserved almost three years after surgery. The detection of ischaemic changes in three cases, in perfusion scan with normal function on stress-echo and on left ventriculogram, led us to warrant on-going follow-up.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Kaku. 1999. [In Process Citation]. https://pubmed.ncbi.nlm.nih.gov/10590660/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗